Document is current
Any future updates will be listed below
-
Authors
Nurmi, Hanna M.
Lätti, Anne M. https://orcid.org/0000-0001-7747-6021
Koskela, Heikki O. https://orcid.org/0000-0002-3386-3262
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05034367 at ClinicalTrials.govDocuments that mention this clinical trial
The Cough Response to Inhaled Mannitol in Healthy Subjects
https://doi.org/10.1007/s00408-024-00755-6
-
Funding
Funding for this research was provided by:
The Foundation of Finnish Anti-Tuberculosis association
The North Savo Regional Fund of the Finnish Cultural Foundation
Kuopion Seudun Hengityssäätiö
University of Eastern Finland
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 5 November 2024
First Online: 28 November 2024
Declarations
:
: Hanna Nurmi has received funding from Foundation of the Finnish Anti-Tuberculosis Association and the North Savo Regional Fund of the Finnish Cultural Foundation. Anne Lätti declares no competing interest. Heikki Koskela has received funding from Suomen Tuberkuloosin Vastustamisyhdistyksen säätiö and Kuopion Seudun Hengityssäätiö and owns stocks of Orion Ltd.
: This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Kuopio University Hospital (473/2021) and registered at ClinicalTrials.gov database (, NCT05034367).
: Written informed consent was gathered from all participants.
: Not applicable.
